Skip to main content

Table 6 Clinical performance of triaging all hrHPV+ women with LBC

From: Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

Study

Sensitivity (CIN2+)

Specificity (CIN2+)

Relative cost of Comparator 1

ATHENA (Castle PE et al., 2011 [28])

88.2%

57.8%

− 24%

POBASCAM (Dijkstra M et al., 2013 [32])

66%

81.4%

−26%

PavDag (Stanczuk GA. et al., 2017 [33])

68.3%

89.1%

− 26%

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us